login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
T2 BIOSYSTEMS INC (TTOO) Stock News
USA
- NASDAQ:TTOO -
US89853L3024
-
Common Stock
0.134
USD
-0.06 (-31.07%)
Last: 2/11/2025, 8:00:01 PM
0.12
USD
-0.01 (-10.45%)
After Hours:
2/11/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TTOO Latest News, Press Relases and Analysis
All
Press Releases
10 months ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
10 months ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Third Quarter 2024 Financial Results
a year ago - By: Benzinga
Insights Ahead: T2 Biosystems's Quarterly Earnings
a year ago - By: BusinessInsider
TTOO Stock Earnings: T2 Biosystems Beats EPS, Misses Revenue for Q2 2024
10 months ago - By: T2 Biosystems, Inc.
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
10 months ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems to Host Business Update Call on October 10, 2024
a year ago - By: BusinessInsider
TTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024
a year ago - By: Benzinga
- Mentions:
INTR
LOCL
INV
DLPN
...
Earnings Scheduled For November 14, 2024
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Provides Updates on its New Product Development Pipeline Progress
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems to Attend Upcoming Investor Conferences
a year ago - By: InvestorPlace
- Mentions:
IMNN
JTAI
ENVB
ISPO
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
a year ago - By: InvestorPlace
TTOO Stock Earnings: T2 Biosystems Beats EPS, Misses Revenue for Q2 2024
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Second Quarter 2024 Financial Results
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Regains Compliance with Nasdaq Continued Listing Requirements
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
a year ago - By: InvestorPlace
TTOO Stock Earnings: T2 Biosystems Misses EPS, Beats Revenue for Q1 2024
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
a year ago - By: T2 Biosystems, Inc.
T2 Biosystems Announces First Quarter 2024 Financial Results
Please enable JavaScript to continue using this application.